DarioHealth to Report Second Quarter 2024 Results on Thursday, August 8th
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics market, has announced it will release its financial results for the second quarter of 2024 on Thursday, August 8th, 2024, before the market opens. The company will host a conference call and webcast at 8:30 am Eastern Time on the same day.
The call will be hosted by Erez Raphael, CEO, and Steven Nelson, Chief Commercial Officer. Investors can join via phone or through a Call me™ link. A webcast will also be available. The replay of the call will be accessible until September 8th, 2024.
DarioHealth Corp. (Nasdaq: DRIO), un leader nel mercato globale delle terapie digitali, ha annunciato che pubblicherà i suoi risultati finanziari per il secondo trimestre del 2024 il giovedì 8 agosto 2024, prima dell'apertura del mercato. L'azienda terrà una conference call e un webcast alle 8:30 ora dell'Est dello stesso giorno.
La chiamata sarà guidata da Erez Raphael, CEO, e Steven Nelson, Chief Commercial Officer. Gli investitori potranno partecipare telefonicamente o tramite un link Call me™. Sarà inoltre disponibile un webcast. La registrazione della chiamata sarà accessibile fino al 8 settembre 2024.
DarioHealth Corp. (Nasdaq: DRIO), un líder en el mercado global de terapias digitales, ha anunciado que publicará sus resultados financieros para el segundo trimestre de 2024 el jueves 8 de agosto de 2024, antes de la apertura del mercado. La empresa realizará una conferencia telefónica y un webcast a las 8:30 AM, hora del Este el mismo día.
La llamada será conducida por Erez Raphael, CEO, y Steven Nelson, Director Comercial. Los inversores podrán unirse por teléfono o a través de un enlace Call me™. También estará disponible un webcast. La repetición de la llamada estará accesible hasta el 8 de septiembre de 2024.
DarioHealth Corp. (Nasdaq: DRIO)는 글로벌 디지털 치료제 시장의 선두주자로서 2024년 2분기 재무 결과를 2024년 8월 8일 목요일에 증시 개장 전에 발표할 예정이라고 발표했습니다. 회사는 같은 날 동부 표준시 기준 오전 8시 30분에 전화 회의 및 웹캐스트를 진행할 예정입니다.
이번 회의는 Erez Raphael, CEO와 Steven Nelson, 최고 상업 책임자가 주최합니다. 투자자들은 전화나 Call me™ 링크를 통해 참여할 수 있습니다. 웹캐스트도 제공될 예정입니다. 호출의 재생은 2024년 9월 8일까지 접근할 수 있습니다.
DarioHealth Corp. (Nasdaq: DRIO), un leader sur le marché mondial des thérapies numériques, a annoncé qu'elle publiera ses résultats financiers pour le deuxième trimestre de 2024 le jeudi 8 août 2024, avant l'ouverture des marchés. La société tiendra un appel de conférence et un webcast à 8h30, heure de l'Est le même jour.
L'appel sera animé par Erez Raphael, PDG, et Steven Nelson, Directeur Commercial. Les investisseurs pourront participer par téléphone ou par le biais d'un lien Call me™. Un webcast sera également disponible. La rediffusion de l'appel sera accessible jusqu'au 8 septembre 2024.
DarioHealth Corp. (Nasdaq: DRIO), ein führendes Unternehmen im globalen Markt für digitale Therapeutika, hat bekannt gegeben, dass es seine Finanzergebnisse für das zweite Quartal 2024 am Donnerstag, den 8. August 2024, vor der Markteröffnung veröffentlichen wird. Das Unternehmen wird am selben Tag um 8:30 Uhr Eastern Time eine Konferenzschaltung und einen Webcast veranstalten.
Die Sitzung wird von Erez Raphael, CEO, und Steven Nelson, Chief Commercial Officer, geleitet. Investoren können telefonisch oder über einen Call me™-Link teilnehmen. Ein Webcast wird ebenfalls verfügbar sein. Die Wiederholung des Anrufs wird bis zum 8. September 2024 zugänglich sein.
- None.
- None.
Company to host conference call and webcast at 8:30am ET
Erez Raphael, Chief Executive Officer, and Steven Nelson, Chief Commercial Officer, will host the call.
Conference Call Details
Date: Thursday, August 8th, 8:30am ET
Dial-in Number: 1-800-717-1738 (domestic) or 1-646-307-1865 (international)
Call me™: https://emportal.ink/3V5ogDP
Participants can use the dial-in numbers above and be answered by an operator OR click the Call me™ link for instant telephone access to the event. This link will be made active 15 minutes prior to scheduled start time.
Webcast link: https://viavid.webcasts.com/starthere.jsp?ei=1672806&tp_key=f245af335e
Participants are asked to dial in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through Sunday, September 8th, 2024. To listen to the replay, dial 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and use replay passcode 1163410.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition platform. Our platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Our user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Making the right thing to do the easy thing to do.
Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. To learn more about DarioHealth and its digital health solutions, or for more information, visit http://dariohealth.com.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and partners of DarioHealth Corp. related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses the expected date of its earnings release. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the
DarioHealth Corporate Contact
Mary Mooney
VP Marketing
mary@dariohealth.com
+1-312-593-4280
DarioHealth Investor Relations Contact
Kat Parrella
Investor Relations Manager
kat@dariohealth.com
+315-378-6922
Media Contact:
Scott Stachowiak
Scott.Stachowiak@russopartnersllc.com
+1-646-942-5630
Logo - https://mma.prnewswire.com/media/1920436/DarioHealth_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/dariohealth-to-report-second-quarter-2024-results-on-thursday-august-8th-302209732.html
SOURCE DarioHealth Corp.
FAQ
When will DarioHealth (DRIO) report its Q2 2024 financial results?
What time is DarioHealth's (DRIO) Q2 2024 earnings conference call?
Who will host DarioHealth's (DRIO) Q2 2024 earnings call?
How long will the replay of DarioHealth's (DRIO) Q2 2024 earnings call be available?
